Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.
J Immunother Cancer. 2022 Sep;10(9):e005049. doi: 10.1136/jitc-2022-005049.
J Immunother Cancer. 2022.
PMID: 36100308
Free PMC article.